Zdrowie i gospodarka · 24/06/2019

FDA Releases Final Guidance on Promotional Labeling and Advertising Materials for Human Prescription Drugs

The Food and Drug Administration (FDA) has released a final guidance for the pharmaceutical industry on providing regulatory submissions for promotional labeling and advertising materials of human prescription drugs, including electronic and non-electronic formats. This guidance finalizes a draft released in April 2015.